Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.59 |
| ▸ | CES1 | P23141 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL291493 | 0.98 | CES2 (0.58) | CES2CES1LMNANPC1RAB9A | |
| Acetic Acid SCHEMBL3368380 | 0.97 | CES2 (0.56) | CES2CES1LMNANPC1RAB9A | |
| SCHEMBL28343389 | 0.95 | CES2 (0.54) | CES2CES1LMNANPC1RAB9A | |
| Carbamic Acid SCHEMBL1695357 | 0.95 | CES2 (0.54) | CES2CES1LMNANPC1RAB9A | |
| Phosphoric Acid SCHEMBL9151566 | 0.94 | CES2 (0.53) | CES2CES1LMNANPC1RAB9A | |
| Acrylic Acid SCHEMBL10353178 | 0.91 | CES2 (0.50) | CES2CES1LMNANPC1RAB9A | |
| SCHEMBL3364576 | 0.89 | CES2 (0.47) | CES2CES1LMNANPC1RAB9A | |
| SCHEMBL8622126 | 0.87 | CES2 (0.61) | CES2CES1LMNANPC1RAB9A | |
| SCHEMBL139043 | 0.87 | LMNA (0.59) | CES2CES1LMNANPC1RAB9A | |
| SCHEMBL14181968 | 0.86 | CES2 (0.48) | CES2CES1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2300067-B1 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIV OF BELFAST (GB) | 2017-10-25 | — | — | EP | claimed |
| US-9714560-B2 | Protected scale inhibitors and methods relating thereto | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-07-25 | — | — | US | claimed |
| EP-2727915-B1 | Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof | CONCERT PHARMACEUTICALS INC (US) | 2016-04-13 | — | — | EP | claimed |
| US-20110165114-A1 | DRUG DELIVERY COMPOSITION | QUEEN'S UNIVERSITY OF BELFAST, THE (GB) | 2011-07-07 | — | — | US | claimed |
| EP-2300067-A2 | DRUG DELIVERY COMPOSITION | The Queen's University of Belfast (GB) | 2011-03-30 | — | — | EP | claimed |
| WO-2009147372-A2 | DRUG DELIVERY COMPOSITION | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-12-10 | — | — | WO | claimed |
| EP-1401851-B8 | TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | FEBIT HOLDING GMBH (DE) | 2008-09-10 | — | — | EP | claimed |
| EP-1401851-A1 | TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | Febit AG (DE) | 2004-03-31 | — | — | EP | claimed |
| WO-2003004510-A1 | TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | FEBIT AG (DE) | 2003-01-16 | — | — | WO | claimed |
| EP-0123159-B1 | POSITIVE-WORKING PHOTOSENSITIVE BENZOIN ESTERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-09-05 | — | — | EP | claimed |
| WO-2026090073-A1 | POLYMERIC PARTICLES FOR PROXIMITY-BASED CELLULAR DNA-ENCODED LIBRARY SCREENING AND METHODS OF USE | GENENTECH, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-3434764-B1 | FABRIC AND HOME CARE PRODUCTS | PROCTER & GAMBLE (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20250344929-A1 | Fibrous Structures Comprising Particles and Methods for Making Same | PROCTER & GAMBLE (US) | 2025-11-13 | — | — | US | disclosed |
| EP-4197598-B1 | ACTIVE AGENT-CONTAINING ARTICLES THAT EXHIBIT CONSUMER ACCEPTABLE ARTICLE IN-USE PROPERTIES | PROCTER & GAMBLE (US) | 2025-10-22 | — | — | EP | disclosed |
| US-12440083-B2 | Fibrous structures comprising particles and methods for making same | THE PROCTER & GAMBLE COMPANY (US) | 2025-10-14 | — | — | US | disclosed |
| EP-0046083-B1 | PHOTOLABILE BLOCKED SURFACTANTS AND COMPOSITIONS CONTAINING THE SAME | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-10-16 | — | — | EP | disclosed |
| EP-0123159-A2 | Positive-working photosensitive benzoin esters | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-10-31 | — | — | EP | disclosed |
| US-4478967-A | Photolabile blocked surfactants and compositions containing the same | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-10-23 | — | — | US | disclosed |
| US-4469774-A | RELIEF PRINTING PLATES, PHOTORESISTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-09-04 | — | — | US | disclosed |
| EP-0046083-A2 | Photolabile blocked surfactants and compositions containing the same | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110165114-A1 | DRUG DELIVERY COMPOSITION | ECPAS, ABCB11, ABCB1 | CES2 427/4885CES1 714/4885LMNA 135/4885 |
| US-12440083-B2 | Fibrous structures comprising particles and methods for making same | FGB, CD68, SDCBP | CES2 2307/4885CES1 2200/4885LMNA 166/4885 |
| US-20250344929-A1 | Fibrous Structures Comprising Particles and Methods for Making Same | FGB, CD68, SDCBP | CES2 2307/4885CES1 2200/4885LMNA 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.